Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021238-26-000006

Chief Discovery Officer sold 3,316 shares at $26.61 ($88,239)

From the SEC's structured data for this filing

Trades in this filing

Kreitzer Anatol · Chief Discovery Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-15 Sale : show line 1 in the form −3,316 $26.61 $88,239 256,612 D
Open-market sales · 3,316 sh · avg $26.61 · $88,239
Loading xslF345X06/form4-04172026_040415.xml…